CASP3 and Alzheimer disease: Because we showed an interplay between casp3 activation and Aβ42 oligomers production, we tested the NSAID flurbiprofen described as potential anti-Alzheimer’s disease drug [39] in combination with a pan caspase inhibitor, Z-VAD-fmk.